| scholarly article | Q13442814 |
| P50 | author | Kimberly Page | Q51846987 |
| Judith A. Hahn | Q57881462 | ||
| P2093 | author name string | Jennifer Evans | |
| Meghan D Morris | |||
| Paula J Lum | |||
| Crystal Fuller Lewis | |||
| Daniel Tracy | |||
| Alya Briceño | |||
| P2860 | cites work | Higher clearance of hepatitis C virus infection in females compared with males | Q27478322 |
| Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection | Q28361460 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective | Q30670433 | ||
| Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. | Q33576025 | ||
| Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection | Q33650138 | ||
| Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco | Q34117952 | ||
| Networks, resources and risk among women who use drugs | Q34172408 | ||
| Changes in blood-borne infection risk among injection drug users | Q34772870 | ||
| Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study) | Q36272952 | ||
| Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic | Q36499522 | ||
| The social production of hepatitis C risk among injecting drug users: a qualitative synthesis | Q37281094 | ||
| Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place | Q37306146 | ||
| Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users | Q37429961 | ||
| Viral hepatitis and injection drug use in Appalachian Kentucky: a survey of rural health department clients | Q37463420 | ||
| Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. | Q39544134 | ||
| Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia | Q39768496 | ||
| High incidence of hepatitis C virus reinfection within a cohort of injecting drug users | Q39797179 | ||
| The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users | Q40507515 | ||
| Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size | Q42612571 | ||
| Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion | Q42633467 | ||
| Hepatitis C virus seroconversion among young injection drug users: relationships and risks | Q43041146 | ||
| Notes from the field: risk factors for hepatitis C virus infections among young adults--Massachusetts, 2010. | Q43041805 | ||
| Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco | Q43657708 | ||
| A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users | Q44109037 | ||
| Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users | Q44116660 | ||
| Gender differences in HIV risk behaviors among young injectors and their social network members | Q44125363 | ||
| Notes from the field : hepatitis C virus infections among young adults--rural Wisconsin, 2010. | Q45357595 | ||
| Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009. | Q45366817 | ||
| Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users--new York, November 2004-April 2007. | Q45395054 | ||
| Gender differences in risk behaviors among HIV+ persons with an IDU history. The link between partner characteristics and women's higher drug-sex risks. The Manif 2000 Study Group. | Q50859312 | ||
| Young and recent-onset injecting drug users are at higher risk for HIV. | Q52275816 | ||
| Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. | Q54135674 | ||
| Hepatitis C prevention education needs to be grounded in social relationships | Q57773511 | ||
| Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand | Q73682509 | ||
| P433 | issue | 5 | |
| P921 | main subject | Hepatitis C virus | Q708693 |
| sexually transmitted infection | Q12198 | ||
| hepatitis C | Q154869 | ||
| sexual transmission | Q45349134 | ||
| P304 | page(s) | e004988 | |
| P577 | publication date | 2014-05-29 | |
| P1433 | published in | BMJ Open | Q17003470 |
| P1476 | title | Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort | |
| P478 | volume | 4 |
| Q90160343 | A Phylogenetic Analysis of HCV Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy |
| Q47234297 | A Study of Sexual Relationship Power Among Young Women Who Inject Drugs and Their Sexual Partners. |
| Q49887780 | Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review. |
| Q35817533 | Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions |
| Q40144468 | Correlates of Injection Drug Use Among Rural Appalachian Women |
| Q38627006 | Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships. |
| Q47549256 | Do women with complex alcohol and other drug use histories want women-only residential treatment? |
| Q64135724 | Dual Unsafe Injection and Sexual Behaviors for HIV Infection Among People Who Inject Drugs in Iran |
| Q90743384 | Gender-based vulnerability in women who inject drugs in a harm reduction setting |
| Q46119171 | HIV and adolescents: focus on young key populations |
| Q26991563 | HIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and Treatment |
| Q60923918 | Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care |
| Q45324363 | Hepatitis C virus prevalence and associated risk factors among Indigenous Australians who inject drugs. |
| Q38993437 | Higher incidence of HCV in females compared to males who inject drugs: A systematic review and meta-analysis |
| Q92441467 | Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships |
| Q40668892 | Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study |
| Q63684293 | Management of acute HCV infection in the era of direct-acting antiviral therapy |
| Q36248999 | More than just someone to inject drugs with: Injecting within primary injection partnerships |
| Q40048259 | Needle syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. |
| Q42720607 | Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs |
| Q90196120 | Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study |
| Q35131217 | Providing comprehensive health services for young key populations: needs, barriers and gaps |
| Q92299256 | Risk Factors Associated with Linkage to Care among Suburban Hepatitis C-Positive Baby Boomers and Injection Drug Users |
| Q59799640 | Serodiscordant partnerships and opportunities for pre-exposure prophylaxis among partners of women and men living with HIV in St. Petersburg, Russia |
| Q41919161 | The effect of female sex on hepatitis C incidence among people who inject drugs: results from the international multi-cohort InC3 Collaborative. |
| Q36701887 | The role of social networks and geography on risky injection behaviors of young persons who inject drugs |
Search more.